Canada - English - Health Canada

aa pharma inc - theophylline - tablet (extended-release) - 100mg - theophylline 100mg - respiratory smooth muscle relaxants

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg - indications and usage theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. contraindications theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product. pediatric use theophylline is safe and effective for the approved indications in pediatric patients. the maintenance dose of theophylline must be selected with caution in pediatric patients since the rate of theophylline clearance is highly variable across the age range of neonates to adolescents (see clinical pharmacology, table i, warnings, and dosage and administration, table v). geriatric use elderly patients are at significantly greater risk of experiencing serious toxicity from theophylline than younger patients due to pharmacokinetic and pharmacodynamic changes associated

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - theophylline, quantity: 100 mg - capsule - excipient ingredients: colloidal anhydrous silica; ethylcellulose; shellac; purified talc; sunset yellow fcf; titanium dioxide; gelatin; maize starch; sucrose - theo-24 is indicated for the relief and/or prevention of symptoms of asthma and for reversable bronchospasm associated with chronic bronchitis and emphysema.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Canada - English - Health Canada

pro doc limitee - theophylline - elixir - 80mg - theophylline 80mg - respiratory smooth muscle relaxants

Canada - English - Health Canada

desbergers ltÉe, division of technilab inc. - theophylline - liquid - 80mg - theophylline 80mg - respiratory smooth muscle relaxants

Canada - English - Health Canada

rougier pharma division of ratiopharm inc - theophylline; alcohol anhydrous - elixir - 80mg; 3ml - theophylline 80mg; alcohol anhydrous 3ml - respiratory smooth muscle relaxants

Canada - English - Health Canada

astrazeneca canada inc - theophylline - tablet (extended-release) - 100mg - theophylline 100mg - respiratory smooth muscle relaxants

Canada - English - Health Canada

astrazeneca canada inc - theophylline - tablet (extended-release) - 200mg - theophylline 200mg - respiratory smooth muscle relaxants